Developing combination products—such as drug-eluting stents, growth factor-releasing bone void fillers, or cell-seeded scaffolds—poses unique challenges because these products involve both medical device and drug/biologic regulations. Unlike standalone medical devices, combination products require careful coordination between different regulatory pathways, often…   Read more»